Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management.
Where this comes from
- Record sourced from PubMed, PMID 38319876.
- Also identified by DOI 10.1056/EVIDx2200180.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the Original Article, "Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management," originally published February 3, 2022 (DOI: 10.1056/EVIDoa2100028), under the Results section, in the first paragraph titled "Prespecified Secondary Outcomes" where the text reads "…(risk difference, 13.4; 95% CI, -∞ to -3.9)" should have read "…(risk difference, -13.4; 95% CI, -∞ to -3.9)". A corrected version of the article has been posted at evidence.nejm.org.